Works matching IS 20504365 AND DT 2025 AND VI 12 AND IP 1/2

Results: 2
    1

    Connectivity guided intermittent theta burst stimulation versus repetitive transcranial magnetic stimulation in moderately severe treatment resistant depression.

    Published in:
    Efficacy & Mechanism Evaluation (EME), 2025, v. 12, n. 1/2, p. 1, doi. 10.3310/WVNY5029
    By:
    • Morriss, Richard;
    • Webster, Lucy;
    • Ingram, Luke;
    • Abdelghani, Mohamed;
    • Anton, Adriana;
    • Barber, Shaun;
    • Bates, Peter;
    • Briley, Paul;
    • Boutry, Clement;
    • Brookes, Cassandra;
    • Cox, Edward;
    • Hall, Beth;
    • James, Marilyn;
    • Keane, Matthew;
    • Kurkar, Micheal;
    • Lankappa, Sudheer;
    • Liddle, Peter;
    • McAllister-Williams, Hamish;
    • Oh, Hyerin;
    • O'Neill-Kerr, Alexander
    Publication type:
    Article
    2

    The efficacy and safety of ustekinumab in adolescents newly diagnosed with type 1 diabetes: the USTEK1D RCT.

    Published in:
    Efficacy & Mechanism Evaluation (EME), 2025, v. 12, n. 1/2, p. 1, doi. 10.3310/FQLN7416
    By:
    • Carter, Kymberley;
    • Cheung, Wai-Yee;
    • Hutchings, Hayley A;
    • Fegan, Greg;
    • Holland, Gail;
    • Luzio, Steve;
    • Dunseath, Gareth;
    • Hiles, Stephen;
    • Marques-Jones, Susie;
    • Gregory, John W;
    • Tatovic, Danijela;
    • Taylor, Peter;
    • Bowen-Morris, Jane;
    • Stenson, Rachel;
    • Hanna, Stephanie;
    • Mahmood, Zainab;
    • Yang, Jennie;
    • Williams, Evangelia;
    • Tree, Timothy;
    • Marwaha, Ashish
    Publication type:
    Article